US Patent 11364230 Amlodipine formulations
Patent 11364230 was granted and assigned to Azurity Pharmaceuticals on June, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
March 5, 2021
Date of Patent
June 21, 2022
Patent Applicant
Patent Application Number
17194016
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11364230 Amlodipine formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
